BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.76% |
| 2 | Healthcare | 6.75% |
| 3 | Financials | 5.74% |
| 4 | Consumer Discretionary | 5.28% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
CareTrust REIT
CTRE
$9.16B
| $1.33M | ﹤0.01% |
90,009
-21,200
| -19% | -$421K |
|
1602
Protolabs
PRLB
$2.2B
| $1.33M | ﹤0.01% |
17,423
+8,524
| +96% | +$790K |
|
1603
JetBlue
JBLU
$2.13B
| $1.33M | ﹤0.01% |
148,131
-139,914
| -49% | -$2.32M |
|
1604
PUT
Zions Bancorporation
ZION
$10.5B
| $1.32M | ﹤0.01% |
495
-1,005
| -67% | -$41.4K |
|
1605
PUT
Ecolab
ECL
$77.4B
| $1.32M | ﹤0.01% |
85
-117
| -58% | -$22K |
|
1606
Acco Brands
ACCO
$401M
| $1.32M | ﹤0.01% |
262,266
+43,453
| +20% | +$344K |
|
1607
First Industrial Realty Trust
FR
$8.33B
| $1.32M | ﹤0.01% |
39,807
+2,058
| +5% | +$81.7K |
|
|
AYX
1608
DELISTED
Alteryx Inc
AYX
| $1.32M | ﹤0.01% |
13,888
-12,559
| -47% | -$1.56M |
|
|
MODV
1609
DELISTED
ModivCare
MODV
| $1.32M | ﹤0.01% |
24,031
+21,049
| +706% | +$1.3M |
|
1610
Banco Macro
BMA
$4.96B
| $1.32M | ﹤0.01% |
77,446
+12,534
| +19% | +$359K |
|
|
ENIA
1611
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $1.31M | ﹤0.01% |
216,209
+214,709
| +14,314% | +$1.93M |
|
1612
Agilysys
AGYS
$3.22B
| $1.31M | ﹤0.01% |
78,323
+73,103
| +1,400% | +$2M |
|
1613
CALL
Zoetis
ZTS
$30.5B
| $1.31M | ﹤0.01% |
111
-126
| -53% | -$16.6K |
|
1614
Harmonic Inc
HLIT
$1.51B
| $1.3M | ﹤0.01% |
226,299
+199,452
| +743% | +$1.34M |
|
|
BBBY
1615
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.3M | ﹤0.01% |
308,811
+180,213
| +140% | +$2.1M |
|
|
FOLD
1616
DELISTED
Amicus Therapeutics
FOLD
| $1.3M | ﹤0.01% |
140,191
+102,177
| +269% | +$971K |
|
|
AVX
1617
DELISTED
AVX Corporation
AVX
| $1.29M | ﹤0.01% |
59,767
+46,367
| +346% | +$974K |
|
1618
WesBanco
WSBC
$4.09B
| $1.29M | ﹤0.01% |
54,611
+36,572
| +203% | +$1.14M |
|
|
MNTV
1619
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $1.29M | ﹤0.01% |
95,559
+80,835
| +549% | +$1.39M |
|
1620
CALL
Hartford Financial Services
HIG
$37.8B
| $1.29M | ﹤0.01% |
366
-11
| -3% | -$573 |
|
1621
Community Bank
CBU
$3.46B
| $1.29M | ﹤0.01% |
21,870
+9,237
| +73% | +$599K |
|
1622
eHealth
EHTH
$39.1M
| $1.28M | ﹤0.01% |
9,120
+3,510
| +63% | +$402K |
|
1623
Core Laboratories
CLB
$571M
| $1.28M | ﹤0.01% |
124,170
+75,781
| +157% | +$2.12M |
|
1624
Progress Software
PRGS
$1.79B
| $1.28M | ﹤0.01% |
39,883
-35,418
| -47% | -$1.43M |
|
1625
Vanguard Total International Bond ETF
BNDX
$82.7B
| $1.27M | ﹤0.01% |
+22,650
| New | +$1.29M |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.